Loss of Gata3 in transgenic mice stimulates mammary luminal tumor progression [27, 28] and overexpression of GATA3 suppresses epithelial-mesenchymal transition (EMT) in cancer cell lines [29, 30]. The gene discussed is GATA3; the disease is cancer.